Collectively, our findings suggest the PIAS1-SnoN sumoylation pathway may play a fundamental role in suppression of human breast cancer invasiveness and potentially metastasis, and identify PIAS1 as a biomarker that predicts improved survival of breast cancer patients. This evidence concerns the gene SKIL and breast carcinoma.